Intraday BUY SELL Signals
62 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement
Advertisement
GINX vs GSK
GINX vs GSK Comparison
Open Charts GINX vs GSK
SGI Enhanced Global Income ETF
Price$30.80
Change+$0.22 (+0.72%)
Volume$16.26K
Net Assets78.57M
GINX vs GSK Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
GINX vs. GSK commentary
Dec 04, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GINX is a StrongBuy and GSK is a StrongBuy.
SUMMARIES
FUNDAMENTALS RATINGS
GSK: Fundamental Ratings
GSK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 9 Undervalued | |
PROFIT vs RISK RATING 1..100 | 37 | |
SMR RATING 1..100 | 40 | |
PRICE GROWTH RATING 1..100 | 43 | |
P/E GROWTH RATING 1..100 | 87 | |
SEASONALITY SCORE 1..100 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TECHNICAL ANALYSIS
Technical Analysis
| GINX | GSK | |
|---|---|---|
| RSI ODDS (%) | 7 days ago 54% | 7 days ago 51% |
| Stochastic ODDS (%) | 7 days ago 50% | 7 days ago 29% |
| Momentum ODDS (%) | 7 days ago 90% | 7 days ago 43% |
| MACD ODDS (%) | 7 days ago 90% | 7 days ago 43% |
| TrendWeek ODDS (%) | 7 days ago 88% | 7 days ago 62% |
| TrendMonth ODDS (%) | 7 days ago 85% | 7 days ago 57% |
| Advances ODDS (%) | 7 days ago 90% | 9 days ago 60% |
| Declines ODDS (%) | 15 days ago 62% | 15 days ago 50% |
| BollingerBands ODDS (%) | 7 days ago 67% | 7 days ago 38% |
| Aroon ODDS (%) | 7 days ago 88% | 7 days ago 49% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BLUC | 28.73 | 0.14 | +0.49% |
| Bluemonte Large Cap Core ETF | |||
| SDG | 84.90 | 0.10 | +0.12% |
| iShares MSCI Global Sust Dev Goals ETF | |||
| EET | 78.10 | 0.06 | +0.08% |
| ProShares Ultra MSCI Emerging Markets | |||
| MINT | 100.31 | 0.01 | +0.01% |
| PIMCO Enhanced Short Maturity Active ETF | |||
| INDY | 52.93 | -0.39 | -0.73% |
| iShares India 50 ETF | |||
GINX and
Correlation & Price change
A.I.dvisor tells us that GINX and GSK have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GINX and GSK's prices will move in lockstep.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To GINX | 1D Price Change % | ||
|---|---|---|---|---|
| GINX | 100% | +0.12% | ||
| GSK - GINX | 25% Poorly correlated | +2.34% | ||
| FMS - GINX | 23% Poorly correlated | +0.38% | ||
| SMFG - GINX | 23% Poorly correlated | +2.15% | ||
| SONY - GINX | 23% Poorly correlated | -0.75% | ||
| RELX - GINX | 23% Poorly correlated | N/A | ||
More | ||||
GSK and
Correlation & Price change
A.I.dvisor indicates that over the last year, GSK has been closely correlated with NVS. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if GSK jumps, then NVS could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y